Literature DB >> 30338718

Uncommon immune-mediated extrahepatic manifestations of HCV infection.

Ciro Romano1, Giovanna Cuomo1, Roberta Ferrara1, Andrea Del Mastro1,2, Sergio Esposito1, Ausilia Sellitto1,3, Luigi Elio Adinolfi1.   

Abstract

INTRODUCTION: Chronic hepatitis C virus (HCV) infection has been associated with myriad extrahepatic manifestations, often resulting from aberrant immune responses. Among the most common immune-mediated manifestations of HCV infection, mixed cryoglobulinemia is the best known extra-hepatic complication. Areas covered: Here we review less common extrahepatic manifestations of HCV infection, with ascertained or presumed immune pathogenesis and the role of the new all oral direct-acting antiviral agents. Rheumatologic, dermatologic, ophthalmologic, renal, pulmonary, hematologic, cardiovascular, and neuropsychiatric manifestations of HCV infection have been considered. Expert commentary: Pathogenesis of HCV-induced aberrant immune responses resulting in peculiar clinical manifestations is not restricted to a single mechanism. A sound approach would therefore consider implementation of an etiologic treatment, through use of antiviral medications, to stop upstream in the pathogenic process all the immune mechanisms leading to hepatic and extrahepatic abnormalities. With the recent introduction of interferon-free, direct antiviral agents, capable of warranting cure for nearly all HCV-infected patients subjected to therapy, both common and uncommon extrahepatic manifestations of chronic hepatitis C are expected to no longer constitute a matter of comorbidity in the course of HCV infection.

Entities:  

Keywords:  HCV; cardiovascular; dermatologic; extrahepatic; hematologic; neuropsychiatric manifestations; ophthalmologic; pulmonary; renal; rheumatologic

Mesh:

Substances:

Year:  2018        PMID: 30338718     DOI: 10.1080/1744666X.2018.1538790

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  5 in total

1.  Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Antonio Russo; Mariantonietta Pisaturo; Clarissa Camaioni; Roberta Astorri; Nicola Coppola
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral Treatment.

Authors:  Ciro Romano; Olga Tortorella; Liliana Dalla Mora; Dario Di Stasio; Ausilia Sellitto; Luigi Elio Adinolfi; Aldo Marrone
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

Review 3.  Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases.

Authors:  Joel Henrique Ellwanger; Bruna Kulmann-Leal; Valéria de Lima Kaminski; Andressa Gonçalves Rodrigues; Marcelo Alves de Souza Bragatte; José Artur Bogo Chies
Journal:  Virus Res       Date:  2020-05-30       Impact factor: 3.303

Review 4.  Human hepatitis viruses-associated cutaneous and systemic vasculitis.

Authors:  Chrong-Reen Wang; Hung-Wen Tsai
Journal:  World J Gastroenterol       Date:  2021-01-07       Impact factor: 5.742

5.  Morphological Changes in the Oral Mucous Membrane in Viral Hepatitis C Patients: A Cross-Sectional Study.

Authors:  Vahe Azatyan; Lazar Yessayan; Aelita Sargsyan; Anna Khachatryan; Tigran Ghevondyan; Melanya Shmavonyan; Gayane Melik-Andreasyan; Kristina Porksheyan; Mikael Manrikyan
Journal:  Int J Environ Res Public Health       Date:  2022-07-24       Impact factor: 4.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.